Cargando…

Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma–COPD overlap (ACO): a scoping review protocol

INTRODUCTION: During the last decade, many articles have been published, including reviews on fractional exhaled nitric oxide (FeNO) use and utility in clinical practice and for monitoring and identifying eosinophilic airway inflammation, especially in asthma, and evaluating corticosteroid responsiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mostafavi-Pour-Manshadi, Seyed-Mohammad-Yousof, Naderi, Nafiseh, Barrecheguren, Miriam, Dehghan, Abolfazl, Bourbeau, Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778315/ https://www.ncbi.nlm.nih.gov/pubmed/29273668 http://dx.doi.org/10.1136/bmjopen-2017-018954

Ejemplares similares

Evaluation of the diagnostic accuracy of fractional exhaled nitric oxide (FeNO) in patients with suspected asthma: study protocol for a prospective diagnostic study
por: Kellerer, Christina, et al.
Publicado: (2021)

Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes
por: Gemicioglu, Bilun, et al.
Publicado: (2014)

Fractional exhaled nitric oxide (FeNO) measurement in asthma and rhinitis
por: Gevorgyan, Artur, et al.
Publicado: (2013)

Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023)

Unusual Side Effects of Interferon Beta-1a in Patient with Multiple Sclerosis
por: Tavakoli, Maryam, et al.
Publicado: (2012)

Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap
por: Ingebrigtsen, Truls Sylvan, et al.
Publicado: (2020)

ACO (Asthma–COPD Overlap) Is Independent from COPD: The Case Against
por: Calverley, Peter M. A., et al.
Publicado: (2021)

Importance of fractional exhaled nitric oxide in the differentiation of asthma–COPD overlap syndrome, asthma, and COPD
por: Chen, Feng-jia, et al.
Publicado: (2016)

Does FeNO Predict Clinical Characteristics in Chronic Cough?
por: Sadeghi, Mahboobeh Haji, et al.
Publicado: (2017)

Role of pulmonary function and FeNO detection in early screening of patients with ACO
por: Wang, Jing, et al.
Publicado: (2020)

296 The Relationship of Fractional Exhaled Nitric Oxide (FeNO) and Acute Exacerbation of Childhood Asthma
por: Rha, Yeong Ho, et al.
Publicado: (2012)

The Effect of Adiposity Markers on Fractional Exhaled Nitric Oxide (FeNO) and Pulmonary Function Measurements
por: Al Khathlan, Noor, et al.
Publicado: (2020)

Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews
por: Santillo, Marta, et al.
Publicado: (2022)

Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases
por: Ragnoli, Beatrice, et al.
Publicado: (2023)

The Asthma COPD Overlap Syndrome: ACOS Epidemiology and Historical Perspective
por: van den Berge, Maarten
Publicado: (2017)

The Asthma COPD Overlap Syndrome: ACOS. Epidemiology and Historical Perspective
por: van den Berge, Maarten
Publicado: (2017)

Update on Asthma–COPD Overlap (ACO): A Narrative Review
por: Mekov, Evgeni, et al.
Publicado: (2021)

Differential DAMP release was observed in the sputum of COPD, asthma and asthma-COPD overlap (ACO) patients
por: Huang, Xiaolin, et al.
Publicado: (2019)

Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma
por: Brooks, Elizabeth A, et al.
Publicado: (2019)

Fractional exhaled Nitric Oxide (FeNO) level as a predictor of COVID-19 disease severity
por: Lior, Yotam, et al.
Publicado: (2022)

The role of exhaled nitric oxide (FeNO) in the evaluation of lung parenchymal involvement in COVID-19 patients
por: Kerget, Buğra, et al.
Publicado: (2022)

Ambient Environmental Ozone and Variation of Fractional Exhaled Nitric Oxide (FeNO) in Hairdressers and Healthcare Workers
por: Hildre, Tonje Trulssen, et al.
Publicado: (2023)

Factors Influencing the Concentration of Exhaled Nitric Oxide (FeNO) in School Children Aged 8–9-Years-Old in Krakow, with High FeNO Values ≥ 20 ppb
por: Czubaj-Kowal, Marta, et al.
Publicado: (2022)

Prevalence and Risk Factors of ACO (Asthma-COPD Overlap) in Aboriginal People
por: Koleade, Adetola, et al.
Publicado: (2018)

Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO)
por: Ghosh, Nilanjana, et al.
Publicado: (2020)

Asthma and COPD Overlap Syndrome (ACOS): Risk Factors and Contributing Factors
por: Esmaeilzadeh, Hossein, et al.
Publicado: (2022)

ACO (Asthma–COPD Overlap) Is Independent from COPD, a Case in Favor: A Systematic Review
por: Fujino, Naoya, et al.
Publicado: (2021)

Functional Predictors Discriminating Asthma–COPD Overlap (ACO) from Chronic Obstructive Pulmonary Disease (COPD)
por: Kraemer, Richard, et al.
Publicado: (2022)

Cardiac Manifestations of Rheumatological Conditions: A Narrative Review
por: Owlia, Mohammad Bagher, et al.
Publicado: (2012)

Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis
por: Alshabanat, A., et al.
Publicado: (2015)

Clinical Characteristics Of Patients With Asthma COPD Overlap (ACO) In Australian Primary Care
por: Izbicki, Gabriel, et al.
Publicado: (2019)

Optimising treatment for COPD – new strategies for combination therapy
por: Welte, T
Publicado: (2009)

Frailty in asthma-COPD overlap: a cross-sectional study of association and risk factors in the NHANES database
por: Wang, Xinyu, et al.
Publicado: (2023)

Burden of asthma and COPD overlap (ACO) in Taiwan: a nationwide population-based study
por: Shantakumar, Sumitra, et al.
Publicado: (2018)

Asthma-COPD Overlap in Clinical Practice (ACO_CP 2023): Toward Precision Medicine
por: Alsayed, Ahmad R., et al.
Publicado: (2023)

Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma–COPD overlap
por: Takayama, Yusuke, et al.
Publicado: (2018)

Repeatability of exhaled nitric oxide measurements in patients with COPD
por: Rouhos, Annamari, et al.
Publicado: (2011)

Behaviour-change intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation
por: Bourbeau, Jean, et al.
Publicado: (2016)

Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care
por: Price, David, et al.
Publicado: (2013)

Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters
por: Kraemer, Richard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_knvf4j0hjocq9hjfammrg70knc